Home Tools
Log in
Cart

Search Result

Search Results for " gsk3β inhibitor 1 "

18

Compounds

Cat No. Product Name Synonyms Targets
T11467 GSK- inhibitor 1 GSK-3
GSK- inhibitor 1 is an inhibitor of GSK-( IC50 of 4.9 nM) and demonstrates high antidiabetic efficacy.
T9178 (E/Z)-GSK- inhibitor 1 GSK- inhibitor 1 GSK-3
(E/Z)-GSK- inhibitor 1 is a glycogen synthase kinase (GSK-) inhibitor and demonstrates high antidiabetic efficacy.
T8376 PKCβ inhibitor 1 KUN79359 Apoptosis , PKC
PKCβ inhibitor 1 (KUN79359)(KUN79359) is a potent, selective and ATP-competitive inhibitor of PKC isozymes(IC50s of 21 and 5 nM for human PKCβ1 and PKCβ2, respectively).
T12901 SHIP2-IN-1 Phosphatase
SHIP2-IN-1 is a potent SHIP2 inhibitor(IC50 : 2 µM),and used in the research of Alzheimer’s disease.
T62719 AChE/BACE1/GSK-IN-1
AChE/BACE1/GSK-IN-1 is an orally active, blood-brain barrier-transparent, moderately bioavailable triple inhibitor of AChE/BACE1/GSK. AChE/BACE1/GSK-IN-1 can be used to study Alzheimer's disease (AD).
T61578 BRD3731
BRD3731 is a selective inhibitor of GSK, demonstrating an IC50 value of 15 nM for GSK and 215 nM for GSK3α. Due to its inhibitory properties, BRD3731 holds promise for investigating various medical conditions, includ...
T63851 CDK9/10/GSK-IN-1
CDK9/10/GSK-IN-1 is a kinase inhibitor (Flavopiridol analogue) that effectively inhibits HsGSK, HsCDK9/CyclinT, HsCDK5/p25 and HsCDK2/CyclinA with IC50 values of 59 nM, 64 nM, 1.093 μM and 1.725 μM, respectively. CDK...
T73247 PIM1-IN-4 Pim
PIM1-IN-4 (Compound 8) is a potent PIM1 inhibitor with significant inhibitory activity against five additional enzymes: SGK-1, PKA, CaMK-1, GSK, and MSK1, rendering it a potentially useful agent for cancer research [1]...
T83524 (rel)-Tivantinib (rel)-(3R,4R)-ARQ 198,(rel)-ARQ 197
(rel)-Tivantinib is a potent, highly selective inhibitor of the receptor tyrosine kinase c-MET and has additional novel targets, GSK3α and GSK, that are critical in the cellular mechanisms of non-small cell lung cancer...
T61756 APN/AKT-IN-1
APN/AKT-IN-1 is a potent dual inhibitor of aminopeptidase N (APN) and protein kinase B (AKT), exhibiting IC50 values of 0.21 μM and 0.27 μM for APN and AKT inhibition, respectively. This compound effectively suppresses t...
T83557 (3S,4S)-Tivantinib ARQ 198,(3S,4S)-ARQ 197
(3S,4S)-Tivantinib, a potent and highly selective inhibitor of the receptor tyrosine kinase c-MET, targets GSK3α and GSK—two novel enzymes implicated in the pathogenesis of non-small cell lung cancer (NSCLC) [1].
T71947 SGK1 inhibitor
SGK1 inhibitor is an inhibitor of serum- and glucocorticoid-regulated kinase 1 (SGK1) and SGK2. It is selective for SGK1 and SGK2 over SGK3 in the presence of a high concentration of ATP. SGK1 inhibitor prevents phosphor...
T61527 GSK2646264
GSK2646264 (Compound 44) is a highly effective and specific inhibitor of spleen tyrosine kinase (SYK) with a pIC50 of 7.1. In addition to targeting SYK, GSK2646264 also inhibits several other kinases, including LCK, LRRK...
T63040 GNF2133 hydrochloride
GNF2133 hydrochloride is a selective, effective, and orally active DYRK1A inhibitor, able to act on DYRK1A (IC50: 0.0062 μM) and GSK (IC50> 50 μM); GNF2133 hydrochloride showed good proliferative ability and efficacy i...
T82242 HAChE-IN-6
hAChE-IN-6 (compound 51) is a brain-penetrant acetylcholinesterase (AChE) inhibitor exhibiting an IC50 of 0.16 μM. It also demonstrates inhibitory effects on human butyrylcholinesterase (hBuChE) and glycogen synthase kin...
T21675 SB 203580 hydrochloride
Adezmapimod (SB 203580) hydrochloride is a selective ATP-competitive inhibitor of p38 MAPK, displaying IC50 values of 50 nM for SAPK2a/p38 and 500 nM for SAPK2b/p38β2. This compound also inhibits LCK, GSK, and PKBα, al...
T82243 HAChE-IN-5 GSK-3
hAChE-IN-5 (compound 49) is a dual inhibitor of human acetylcholinesterase (hAChE) and human butyrylcholinesterase (hBuChE), exhibiting inhibitory potency with IC50 values of 0.17 μM for both enzymes. Additionally, it de...
T35547 YW1128
YW1128 is an inhibitor of Wnt/β-catenin signaling with an IC50 value of 4.1 nM in a reporter assay.1 It decreases protein levels of β-catenin in the presence of the GSK inhibitor lithium chloride and increases protein ...
TargetMol